Shun Iida

National Institute of Infectious Diseases

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2”.

Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2

Nature(2022)10.1038/s41586-022-04856-1

N/A

10.7DataRank · unranked

293 citations

Maki Kiso, Shun Iida, Masaki Imai, Emi Takashita, Makoto Kuroda +64 more

The SARS-CoV-2 B.1.1.529 Omicron virus causes attenuated infection and disease in mice and hamsters

Research Square(2021)10.21203/rs.3.rs-1211792/v1

N/A

8.4DataRank · unranked

87 citations

Peter Halfmann, Tadashi Maemura, Kiyoko Iwatsuki‐Horimoto, Shun Iida, Maki Kiso +60 more

Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 isolates in rodents

Nature(2022)10.1038/s41586-022-05482-7

N/A

0DataRank · unranked

110 citations

Peter Halfmann, Shun Iida, Seiya Yamayoshi, Yuri Furusawa, Maki Kiso +21 more

Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.08.26.505450

N/A

0DataRank · unranked

8 citations

Shun Iida, Peter Halfmann, Seiya Yamayoshi, Yuichiro Hirata, Kiyoko Iwatsuki‐Horimoto +25 more

Identification of SARS-CoV-2 Mpro inhibitors containing P1’ 4-fluorobenzothiazole moiety highly active against SARS-CoV-2

Nature Communications(2023)10.1038/s41467-023-36729-0

N/A

0DataRank · unranked

45 citations

Kohei Tsuji, Hironori Hayashi, Haydar Bulut, Maki Kiso, Masaki Imai +30 more

Recombinant spike protein vaccines coupled with adjuvants that have different modes of action induce protective immunity against SARS-CoV-2

Vaccine(2023)10.1016/j.vaccine.2023.08.054

N/A

0DataRank · unranked

3 citations

Peter Halfmann, Shun Iida, Yuichiro Hirata, Yuko Sato, Makoto Kuroda +5 more

Correction to “Recombinant Spike protein vaccines coupled with adjuvants that have different modes of action induce protective immunity against SARS-CoV-2” [Vaccine 22 (41) (2023) 6025–6035]

Vaccine(2025)10.1016/j.vaccine.2025.126880

N/A

0DataRank · unranked

0 citations

Peter Halfmann, Shun Iida, Yuichiro Hirata, Yuko Sato, Makoto Kuroda +5 more

SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters

Nature(2022)10.1038/s41586-022-04441-6

N/A

0DataRank · unranked

699 citations

Shun Iida, Kiyoko Iwatsuki‐Horimoto, Tadashi Maemura, Maki Kiso, Suzanne M. Scheaffer +77 more